The U.S. sexual and reproductive health clinics market size is anticipated to reach USD 6.27 billion by 2030, registering a CAGR of 6.53% from 2024 to 2030, according to a new report by Grand View Research, Inc. The industry growth can be attributed to a rise in the use of modern contraceptives and increased awareness among adolescents and young people about sexual health and family planning. Government programs have also contributed to increased access to contraceptives, thereby helping prevent unwanted pregnancies in teenagers. When used correctly, male condoms are 98% effective in preventing pregnancy and STIs including HIV. According to the United Nations Program on HIV/AIDS (UNAIDS), consistent and correct use of condoms provides effective protection against unplanned pregnancy and STDs including HIV. Hence, the use of male condoms is advocated by most of the government and healthcare bodies.
Publicly funded family planning services help women avoid or plan pregnancies. Maternal and Infant Health Initiative (the Initiative) for Medicaid and Children’s Health Insurance Program (CHIP) was established by the Center for Medicaid and CHIP Services (CMCS). The CMCS promotes the use of effective methods of contraception to improve pregnancy timing and health outcomes for both women and children. The U.S. government declared September as sexual health awareness month. In addition, parents are being encouraged to talk to their children regarding sexual health. Helplines are available, which allow women to discuss their sexual issues. This is expected to raise awareness among citizens regarding sexual health and wellness in the country. Such initiatives are expected to boost market growth as young adults seek help and education from clinics.
Request a free sample copy or view report summary: U.S. Sexual And Reproductive Health Clinics Market Report
In 2023, the birth control segment held the largest revenue share due to the easy availability of resources and support for contraceptive services, education, and access to birth control methods
The 15 to 25 years age group segment led the market in 2023 and is anticipated to witness significant growth over the forecast period owing to improved access to confidential reproductive health services and counseling becomes essential for this demographic to address issues, such as sexually transmitted infections (STIs), contraception, and overall sexual health
The publicly supported clinic segment held the largest revenue share in 2023. Publicly supported clinics often contribute to community health initiatives. These clinics are designed to provide comprehensive sexual and reproductive health services & education
In 2020, the U.S. government raised funding of USD 608 million for family planning and reproductive health
Grand View Research has segmented the U.S. sexual and reproductive health clinics market on the basis of service, age group, and ownership:
U.S. Sexual & Reproductive Health Clinics Service Outlook (Revenue, USD Million, 2018 - 2030)
Birth Control
Pregnancy-related Services
Sexually Transmitted Diseases (STDs)
Others
U.S. Sexual & Reproductive Health Clinics Age Group Outlook (Revenue, USD Million, 2018 - 2030)
15 to 25 Years
26 to 35 Years
36 to 44 Years
U.S. Sexual & Reproductive Health Clinics Ownership Outlook (Revenue, USD Million, 2018 - 2030)
Private Provider
Publicly Supported Clinics
Hospital Affiliated and Other Providers
List of Key Players of U.S. Sexual And Reproductive Health Clinics Market
Public Health Solutions
Teton County, WY
RAMSEY COUNTY
Bloom Women’s Health
Planned Parenthood Federation of America Inc.
Pacific Reproductive Center
Male Sexual & Reproductive Health Center
University of Rochester Medical Center Rochester, NY (Golisano Children's Hospital)
"The quality of research they have done for us has been excellent..."